Cargando…
Cultural adaptation of a patient decision-aid for insulin therapy
INTRODUCTION: Patient decision-aids (PDAs) support patients in selecting evidence-based treatment options. PDA is useful only if the user understands the content to make personalised decisions. Cultural adaptation is a process of adjusting health messages so that the information is accurate, relevan...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064126/ https://www.ncbi.nlm.nih.gov/pubmed/32152165 http://dx.doi.org/10.1136/bmjopen-2019-033791 |
_version_ | 1783504821975777280 |
---|---|
author | Tan, Ngiap Chuan Koong Ying Leng, Agnes Phoon Kwong Yun, Ian Wang Zhen, Sinead Paulpandi, Muthulakshmi Lee, Yew Kong Furler, John Car, Josip Ng, Chirk Jenn |
author_facet | Tan, Ngiap Chuan Koong Ying Leng, Agnes Phoon Kwong Yun, Ian Wang Zhen, Sinead Paulpandi, Muthulakshmi Lee, Yew Kong Furler, John Car, Josip Ng, Chirk Jenn |
author_sort | Tan, Ngiap Chuan |
collection | PubMed |
description | INTRODUCTION: Patient decision-aids (PDAs) support patients in selecting evidence-based treatment options. PDA is useful only if the user understands the content to make personalised decisions. Cultural adaptation is a process of adjusting health messages so that the information is accurate, relevant and understandable to users from a different population. A PDA has been developed to assist Malaysian patients with secondary drug failure to initiate insulin therapy to control their type 2 diabetes mellitus (T2DM). Likewise, patients with T2DM in neighbouring Singapore face similar barriers in commencing insulin treatment, which a PDA may facilitate decision-making in selecting personalised therapy. OBJECTIVE: The study aimed to explore the views and perceptions of Singaporean primary care providers on the Malaysia PDA to initiate insulin therapy and described the cultural adaptation process used in the design and development of a new PDA, which would be trialled in a Singapore primary healthcare institution. METHOD: Qualitative research method was deployed to conduct one-to-one in-depth interviews of the healthcare providers at the trial site (SingHealth Polyclinics—SHP), including six primary care physicians and four nurses to gather their views and feedbacks on the Malaysian PDA. The interviews were transcribed, audited and analysed (standard content analysis) to identify themes relating to the content, layout, concerns of the original PDA and suggestions to the design of the new SHP PDA. RESULTS: Cultural adaptation of the new PDA includes change to the overall design, graphics (including pictograms), presentation styles, additional contextualised content (personalisation, subheadings, cost and treatment option), modified phrasing of the subtitles and concerns (choice of words) relevant to the new users. CONCLUSION: A PDA on insulin therapy underwent cultural adaptation before its implementation in another population in a neighbouring country. Its relevance and effectiveness will be evaluated in future research. |
format | Online Article Text |
id | pubmed-7064126 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-70641262020-03-20 Cultural adaptation of a patient decision-aid for insulin therapy Tan, Ngiap Chuan Koong Ying Leng, Agnes Phoon Kwong Yun, Ian Wang Zhen, Sinead Paulpandi, Muthulakshmi Lee, Yew Kong Furler, John Car, Josip Ng, Chirk Jenn BMJ Open Diabetes and Endocrinology INTRODUCTION: Patient decision-aids (PDAs) support patients in selecting evidence-based treatment options. PDA is useful only if the user understands the content to make personalised decisions. Cultural adaptation is a process of adjusting health messages so that the information is accurate, relevant and understandable to users from a different population. A PDA has been developed to assist Malaysian patients with secondary drug failure to initiate insulin therapy to control their type 2 diabetes mellitus (T2DM). Likewise, patients with T2DM in neighbouring Singapore face similar barriers in commencing insulin treatment, which a PDA may facilitate decision-making in selecting personalised therapy. OBJECTIVE: The study aimed to explore the views and perceptions of Singaporean primary care providers on the Malaysia PDA to initiate insulin therapy and described the cultural adaptation process used in the design and development of a new PDA, which would be trialled in a Singapore primary healthcare institution. METHOD: Qualitative research method was deployed to conduct one-to-one in-depth interviews of the healthcare providers at the trial site (SingHealth Polyclinics—SHP), including six primary care physicians and four nurses to gather their views and feedbacks on the Malaysian PDA. The interviews were transcribed, audited and analysed (standard content analysis) to identify themes relating to the content, layout, concerns of the original PDA and suggestions to the design of the new SHP PDA. RESULTS: Cultural adaptation of the new PDA includes change to the overall design, graphics (including pictograms), presentation styles, additional contextualised content (personalisation, subheadings, cost and treatment option), modified phrasing of the subtitles and concerns (choice of words) relevant to the new users. CONCLUSION: A PDA on insulin therapy underwent cultural adaptation before its implementation in another population in a neighbouring country. Its relevance and effectiveness will be evaluated in future research. BMJ Publishing Group 2020-03-08 /pmc/articles/PMC7064126/ /pubmed/32152165 http://dx.doi.org/10.1136/bmjopen-2019-033791 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Diabetes and Endocrinology Tan, Ngiap Chuan Koong Ying Leng, Agnes Phoon Kwong Yun, Ian Wang Zhen, Sinead Paulpandi, Muthulakshmi Lee, Yew Kong Furler, John Car, Josip Ng, Chirk Jenn Cultural adaptation of a patient decision-aid for insulin therapy |
title | Cultural adaptation of a patient decision-aid for insulin therapy |
title_full | Cultural adaptation of a patient decision-aid for insulin therapy |
title_fullStr | Cultural adaptation of a patient decision-aid for insulin therapy |
title_full_unstemmed | Cultural adaptation of a patient decision-aid for insulin therapy |
title_short | Cultural adaptation of a patient decision-aid for insulin therapy |
title_sort | cultural adaptation of a patient decision-aid for insulin therapy |
topic | Diabetes and Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064126/ https://www.ncbi.nlm.nih.gov/pubmed/32152165 http://dx.doi.org/10.1136/bmjopen-2019-033791 |
work_keys_str_mv | AT tanngiapchuan culturaladaptationofapatientdecisionaidforinsulintherapy AT koongyinglengagnes culturaladaptationofapatientdecisionaidforinsulintherapy AT phoonkwongyunian culturaladaptationofapatientdecisionaidforinsulintherapy AT wangzhensinead culturaladaptationofapatientdecisionaidforinsulintherapy AT paulpandimuthulakshmi culturaladaptationofapatientdecisionaidforinsulintherapy AT leeyewkong culturaladaptationofapatientdecisionaidforinsulintherapy AT furlerjohn culturaladaptationofapatientdecisionaidforinsulintherapy AT carjosip culturaladaptationofapatientdecisionaidforinsulintherapy AT ngchirkjenn culturaladaptationofapatientdecisionaidforinsulintherapy |